Beta Bionics
BBNX
17.84
-0.24
-1.33%
Beta Bionics
US · BBNX
#3406 by market cap
Listed 2025
17.84
-0.24
-1.33%
Live - 5344 symbols - heartbeat 81s ago
· 2026-10-08 09:59
Pre-market
18.05
-0.17%
After-hours
18.08
0.00%
- Market cap
- 802.62M
- P/E (TTM)i
- -11.00
- P/Bi
- 3.13
- EPSi
- -1.65
- Div yieldi
- 0.00%
- 52W posi
- 38%
Reader sentiment
Are you bullish or bearish on BBNX?
Anonymous reader poll. Unscientific, not investment advice.
About Beta Bionics
Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.
- Founded
- 2015
- CEO
- Mr. Sean Saint
- Employees
- 423
- Headquarters
- Irvine, California, United States of America
- Fiscal year end
- 12-31
- Website
- betabionics.com
Company profile
- Exchange
- US
- Symbol
- BBNX
- Market-cap rank
- #3406
- Listing date
- 2025-01-30
- Market cap
- 802.62M
- Float cap
- 513.86M
- Shares out
- 44.99M
- Float shares
- 28.80M
Sectors & themes
Quote time 2026-10-08 09:59:48 · For reference only, not investment advice and not tailored to your situation.